ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $15,503 | -74.5% | 9,750 | 0.0% | 0.00% | -75.0% |
| Q4 2022 | $60,743 | -6.5% | 9,750 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $65,000 | 0.0% | 9,750 | -4.2% | 0.00% | +33.3% |
| Q2 2022 | $65,000 | -55.5% | 10,180 | -67.7% | 0.00% | -50.0% |
| Q1 2022 | $146,000 | -7.0% | 31,531 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $157,000 | +1470.0% | 31,531 | +3403.4% | 0.01% | – |
| Q3 2021 | $10,000 | -44.4% | 900 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $18,000 | -25.0% | 900 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $24,000 | 0.0% | 900 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $24,000 | -56.4% | 900 | -38.8% | 0.00% | -66.7% |
| Q3 2020 | $55,000 | -17.9% | 1,470 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $67,000 | +17.5% | 1,470 | -9.3% | 0.00% | 0.0% |
| Q1 2020 | $57,000 | +96.6% | 1,620 | +230.6% | 0.00% | +100.0% |
| Q4 2019 | $29,000 | +38.1% | 490 | -13.0% | 0.00% | +100.0% |
| Q3 2019 | $21,000 | -19.2% | 563 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $26,000 | +18.2% | 563 | 0.0% | 0.00% | +100.0% |
| Q1 2019 | $22,000 | -8.3% | 563 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $24,000 | +14.3% | 563 | +14.9% | 0.00% | +100.0% |
| Q3 2018 | $21,000 | +133.3% | 490 | +96.0% | 0.00% | 0.0% |
| Q2 2018 | $9,000 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |